Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v9-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2020-07-10 | 2019-12-05 |
| Drug Identification Number | 00808539 | 00808539 |
| Brand name | TEVA-DICLOFENAC EC | TEVA-DICLOFENAC EC |
| Common or Proper name | DICLOFENAC 25MG TABLETS | DICLOFENAC 25MG TABLETS |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | DICLOFENAC SODIUM | DICLOFENAC SODIUM |
| Strength(s) | 25MG | 25MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL | ORAL |
| Packaging size | 100 | 100 |
| ATC code | M01AB | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-08-01 | 2020-08-01 |
| Actual start date | ||
| Estimated end date | Unknown | |
| Actual end date | 2020-06-29 | |
| Shortage status | Avoided shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Will be allocating to cover our market until resupply in Aug 2020 | Will be allocating to cover our market until resupply in Aug 2020 |
| Health Canada comments |